Hexaxim®
A3L35
Phase 3 mab completed
Quick answer
Hexaxim® for Diphtheria is a Phase 3 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Diphtheria
- Phase
- Phase 3
- Modality
- mab
- Status
- completed